24162 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 18
00:32 UTC
|
GEMI
Gemini Space Station
|
◎ Target | Brett Knoblauch ★☆☆☆☆ #3057 | Neutral | $7.00→ $5.00-28.6% |
|
Aug 18
00:32 UTC
|
GEMI
Gemini Space Station
|
◎ Target | Chris Brendler ★★★☆☆ #1924 | Buy | $9.00→ $6.00-33.3% |
|
Aug 18
00:32 UTC
|
GEMI
Gemini Space Station
|
◎ Target | John Todaro ★☆☆☆☆ #2977 | Buy | $8.00→ $6.00-25.0% |
|
Aug 18
00:32 UTC
|
GBG
GB Group
|
◎ Target | firm only | Buy | GBX 415→ GBX 345-16.9% |
|
Aug 18
00:32 UTC
|
FWONK
Liberty Media Corporation - Liberty Formula One Series C
|
◎ Target | Curry Baker ★★☆☆☆ #2232 | Buy | $125.00→ $134.00+7.2% |
|
Aug 18
00:32 UTC
|
FRT
Federal Realty Investment Trust
|
◎ Target | Richard Hightower ★★★☆☆ #2054 | Equal Weight | $120.00→ $123.00+2.5% |
|
Aug 18
00:32 UTC
|
FANG
Diamondback Energy
|
◎ Target | Betty Jiang ★★★☆☆ #1387 | Overweight | $232.00→ $221.00-4.7% |
|
Aug 18
00:32 UTC
|
FA
First Advantage
|
◎ Target | Peter Christiansen ★★★★☆ #899 | Neutral | $18.00→ $22.00+22.2% |
|
Aug 18
00:32 UTC
|
EYPT
Eyepoint Pharmaceuticals
|
◎ Target | Kambiz Yazdi ★★★☆☆ #1357 | Buy | $8.00 |
|
Aug 18
00:32 UTC
|
EXE
Expand Energy
|
◎ Target | Betty Jiang ★★★☆☆ #1387 | Equal Weight | $110.00→ $107.00-2.7% |
|
Aug 18
00:32 UTC
|
EVH
Evolent Health
|
◎ Target | Charles Rhyee ★★★★☆ #801 | Buy | $5.00→ $6.00+20.0% |
|
Aug 18
00:32 UTC
|
ESS
Essex Property Trust
|
◎ Target | Richard Hightower ★★★☆☆ #2054 | Equal Weight | $296.00→ $297.00+0.3% |
|
Aug 18
00:32 UTC
|
EQT
EQT
|
◎ Target | Betty Jiang ★★★☆☆ #1387 | Overweight | $70.00→ $68.00-2.9% |
|
Aug 18
00:32 UTC
|
EQPT
EquipmentShare.com
|
◎ Target | Kyle Menges ★★★☆☆ #1967 | Neutral | $19.00→ $22.00+15.8% |
|
Aug 18
00:32 UTC
|
ENT
Entain
|
◎ Target | firm only | Overweight | GBX 1,025→ GBX 1,050+2.4% |
|
Aug 18
00:32 UTC
|
ENT
Entain
|
◎ Target | firm only | Buy | GBX 950→ GBX 914-3.8% |
|
Aug 18
00:32 UTC
|
ENOV
Enovis
|
◎ Target | Caitlin Cronin ★★☆☆☆ #2338 | Buy | $50.00→ $45.00-10.0% |
|
Aug 18
00:32 UTC
|
ENHA
Enhanced Group
|
◎ Target | Susan Anderson ★★★☆☆ #1852 | Buy | $6.00→ $5.00-16.7% |
|
Aug 18
00:32 UTC
|
ELMT
Elmet Group
|
◎ Target | Austin Moeller ★☆☆☆☆ #3106 | Buy | $20.00→ $21.00+5.0% |
|
Aug 18
00:32 UTC
|
EAT
Brinker International
|
◎ Target | Brian Mullan ★★☆☆☆ #2497 | Neutral | $166.00→ $240.00+44.6% |
|
Aug 18
00:32 UTC
|
DVN
Devon Energy
|
◎ Target | Betty Jiang ★★★☆☆ #1387 | Overweight | $62.00→ $58.00-6.5% |
|
Aug 18
00:32 UTC
|
DUK
Duke Energy
|
◎ Target | Richard Sunderland ★★★☆☆ #1687 | Buy | $138.00→ $135.00-2.2% |
|
Aug 18
00:32 UTC
|
DLTR
Dollar Tree
|
◎ Target | Edward Kelly ★★★☆☆ #1583 | Overweight | $145.00→ $155.00+6.9% |
|
Aug 18
00:32 UTC
|
DDS
Dillard's
|
◎ Target | Mauricio Serna ★★★★☆ #750 | Sell | $465.00→ $468.00+0.6% |
|
Aug 18
00:32 UTC
|
DDS
Dillard's
|
◎ Target | Matthew Boss ★★★☆☆ #1820 | Underweight | $496.00→ $519.00+4.6% |
|
Aug 18
00:32 UTC
|
DCH
American Axle & Manufacturing
|
◎ Target | Dan Levy ★★★☆☆ #1792 | Equal Weight | $8.00→ $9.00+12.5% |
|
Aug 18
00:32 UTC
|
CWK
Cushman & Wakefield
|
◎ Target | Brendan Lynch ★★★☆☆ #1965 | Equal Weight | $15.00→ $16.00+6.7% |
|
Aug 18
00:32 UTC
|
CVX
Chevron
|
◎ Target | Betty Jiang ★★★☆☆ #1387 | Equal Weight | $216.00→ $208.00-3.7% |
|
Aug 18
00:32 UTC
|
CVRX
CVRx
|
◎ Target | Sarah James ★★☆☆☆ #2791 | Overweight | $13.00→ $5.00-61.5% |
|
Aug 18
00:32 UTC
|
CTOS
Custom Truck One Source
|
◎ Target | Manish A. Somaiya not yet tracked | Overweight | $13.00→ $14.00+7.7% |
|
Aug 18
00:32 UTC
|
CRDL
Cardiol Therapeutics
|
◎ Target | Edward Nash ★★★☆☆ #1246 | Buy | $8.00→ $10.00+25.0% |
|
Aug 18
00:32 UTC
|
CPT
Camden Property Trust
|
◎ Target | Richard Hightower ★★★☆☆ #2054 | Equal Weight | $122.00→ $123.00+0.8% |
|
Aug 18
00:32 UTC
|
COP
ConocoPhillips
|
◎ Target | Betty Jiang ★★★☆☆ #1387 | Overweight | $155.00→ $150.00-3.2% |
|
Aug 18
00:32 UTC
|
COGT
Cogent Biosciences
|
◎ Target | Christopher Raymond ★★☆☆☆ #2268 | Overweight | $52.00→ $55.00+5.8% |
|
Aug 18
00:32 UTC
|
CMCX
CMC Markets
|
◎ Target | firm only | Outperform | GBX 460→ GBX 760+65.2% |
|
Aug 18
00:32 UTC
|
CELC
Celcuity
|
◎ Target | Brad Canino not yet tracked | Buy | $165.00→ $175.00+6.1% |
|
Aug 18
00:32 UTC
|
CDXS
Codexis
|
◎ Target | Kashy Harrison not yet tracked | Overweight | $9.00→ $8.00-11.1% |
|
Aug 18
00:32 UTC
|
CBRE
CBRE Group
|
◎ Target | Brendan Lynch ★★★☆☆ #1965 | Overweight | $180.00→ $183.00+1.7% |
|
Aug 18
00:32 UTC
|
BVS
Bioventus
|
◎ Target | Caitlin Cronin ★★☆☆☆ #2338 | Buy | $15.00→ $19.00+26.7% |
|
Aug 18
00:32 UTC
|
BURL
Burlington Stores
|
◎ Target | Jay Sole ★★☆☆☆ #2581 | Buy | $435.00→ $440.00+1.1% |
|
Aug 18
00:32 UTC
|
BTGO
BTGO
|
◎ Target | Gareth Gacetta not yet tracked | Overweight | $15.00→ $13.00-13.3% |
|
Aug 18
00:32 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Eliana Merle ★★★★☆ #615 | Overweight | $105.00→ $111.00+5.7% |
|
Aug 18
00:32 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Allison Bratzel ★★★★☆ #781 | Overweight | $82.00→ $88.00+7.3% |
|
Aug 18
00:32 UTC
|
BLSH
Bullish
|
◎ Target | Joseph Vafi ★☆☆☆☆ #2998 | Buy | $50.00→ $45.00-10.0% |
|
Aug 18
00:32 UTC
|
AVBP
ArriVent BioPharma
|
◎ Target | Robert Burns ★★★☆☆ #2044 | Buy | $44.00→ $47.00+6.8% |
|
Aug 18
00:32 UTC
|
AVB
AvalonBay Communities
|
◎ Target | Richard Hightower ★★★☆☆ #2054 | Equal Weight | $205.00→ $206.00+0.5% |
|
Aug 18
00:32 UTC
|
AV
Aviva
|
◎ Target | firm only | Buy | GBX 800→ GBX 820+2.5% |
|
Aug 18
00:32 UTC
|
AROC
Archrock
|
◎ Target | Elvira Scotto ★★★☆☆ #1196 | Outperform | $44.00→ $46.00+4.5% |
|
Aug 18
00:32 UTC
|
ARGX
argenex
|
◎ Target | Allison Bratzel ★★★★☆ #781 | Overweight | $1,075.00→ $1,215.00+13.0% |
|
Aug 18
00:32 UTC
|
ARDX
Ardelyx
|
◎ Target | Christopher Raymond ★★☆☆☆ #2268 | Overweight | $16.00→ $15.00-6.2% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.